World Literature on Medicinal Plants from Pankaj Oudhia’s Medicinal Plant Database -62
World Literature
on Medicinal Plants from Pankaj Oudhia’s Medicinal Plant Database -62
World Literature on Medicinal Plants
Quoted/Consulted/Modified/Improved/Discussed/Used/Corrected in Pankaj Oudhia’s
Medicinal Plant Database.
Oudhia, P. (2009). Traditional Agricultural
Knowledge in Indian state Chhattisgarh. 1.
Management of Nephotettix sp. in Rice (Oryza sativa)
crop. 41. Mitragyna parviflora+
Cleistanthus collinus based formulation (With 20
Herbs) . CGBD (Offline Database on
Chhattisgarh Biodiversity), Raipur, India.
Oudhia, P. (2009). Traditional Agricultural
Knowledge in Indian state Chhattisgarh. 1.
Management of Nephotettix sp. in Rice (Oryza sativa)
crop. 42. Mitragyna parviflora+
Cleistanthus collinus based formulation (With 21
Herbs) . CGBD (Offline Database on
Chhattisgarh Biodiversity), Raipur, India.
Oudhia, P. (2009). Traditional Agricultural
Knowledge in Indian state Chhattisgarh. 1.
Management of Nephotettix sp. in Rice (Oryza sativa)
crop. 43. Mitragyna parviflora+
Cleistanthus collinus based formulation (With 24
Herbs) . CGBD (Offline Database on
Chhattisgarh Biodiversity), Raipur, India.
Oudhia, P. (2009). Traditional Agricultural
Knowledge in Indian state Chhattisgarh. 1.
Management of Nephotettix sp. in Rice (Oryza sativa)
crop. 44. Mitragyna parviflora+
Cleistanthus collinus based formulation (With 25
Herbs) . CGBD (Offline Database on
Chhattisgarh Biodiversity), Raipur, India.
Oudhia, P. (2009). Traditional Agricultural
Knowledge in Indian state Chhattisgarh. 1.
Management of Nephotettix sp. in Rice (Oryza sativa)
crop. 45. Mitragyna parviflora+
Cleistanthus collinus based formulation (With 28
Herbs) . CGBD (Offline Database on
Chhattisgarh Biodiversity), Raipur, India.
Oudhia, P. (2009). Traditional Agricultural
Knowledge in Indian state Chhattisgarh. 1.
Management of Nephotettix sp. in Rice (Oryza sativa)
crop. 46. Mitragyna parviflora+
Cleistanthus collinus based formulation (With 29
Herbs) . CGBD (Offline Database on
Chhattisgarh Biodiversity), Raipur, India.
Oudhia, P. (2009). Traditional Agricultural
Knowledge in Indian state Chhattisgarh. 1.
Management of Nephotettix sp. in Rice (Oryza sativa)
crop. 47. Neem (Azadirachta
indica) based formulation (With 2 Herbs) . CGBD
(Offline Database on Chhattisgarh
Biodiversity), Raipur, India. Oudhia, P. (2009). Traditional Agricultural
Knowledge in Indian state Chhattisgarh. 1.
Management of Nephotettix sp. in Rice (Oryza sativa)
crop. 48. Neem (Azadirachta
indica) based formulation (With 3 Herbs) . CGBD
(Offline Database on Chhattisgarh
Biodiversity), Raipur, India.
Oudhia, P. (2009). Traditional Agricultural
Knowledge in Indian state Chhattisgarh. 1.
Management of Nephotettix sp. in Rice (Oryza sativa)
crop. 49. Neem (Azadirachta
indica) based formulation (With 5 Herbs) . CGBD
(Offline Database on Chhattisgarh
Biodiversity), Raipur, India.
Oudhia, P. (2009). Traditional Agricultural
Knowledge in Indian state Chhattisgarh. 1.
Management of Nephotettix sp. in Rice (Oryza sativa)
crop. 50. Neem (Azadirachta
indica) based formulation (With 6 Herbs) . CGBD
(Offline Database on Chhattisgarh
Biodiversity), Raipur, India.
13. Thongprasom K, Luagjarmekorn L, Seretat T,
Tawesaap W.
Relative efficacy of fluocinolone acetonide compared
with
triamcinolone acetonide in the treatment of oral
lichen planus.
J Oral Pathol Med 1992; 21:456-8.
14. Choi SW, Son BW, Son YS. The wound-healing
effect of a
glycoprotein fraction isolated from aloe vera. Br J
Dermatol 2001;
145:535-45.
15. Shelton
RM. Aloe vera; its chemical and therapeutic properties.
Int J Dermatol1991; 30:679-83.
16. Yagi A, Kabash A, Okamura N, Haraguchi H,
Moustafa SM,
Khalifa TI. Antioxidant, free radical scavenging and
antiinflammatory effects of aloesin derivatives in aloe vera.
Planta Med 2002; 68:957-60.
17. Duansak
D, Somboonwong J, Patumraj S. Effects of aloe vera
on leukocyte adhesion and TNF-alpha and IL-6 levels
in burn
wounded rats. Clin Hemorheol Microcirc 2003;
29:239-46.
18. Gallagher J, Gray M. Is aloe vera effective for
healing chronic
wounds? J Wound Ostomy Continence Nurs 2003;
30:68-71.
Grindlay, D. and T. Reynolds. 1986. The
Aloe vera phenomenon: A review of the properties and modern uses
of the leaf parenchyma gel. J. Ethnopharmacol. 16:117–151.
Morton, J.F.
1961. Folk uses and commercial
exploitation of Aloe leaf pulp. Econ.
Bot. 15:311–319.
MSTAT-C.
1990. A microcomputer program for
the design management and analysis of agronomic research
experiments.
MSTAT, Michigan States Univ., East Lansing.
Yépez, L.M., M.L. Díaz, E. Granadillo, and F.
Chacín. 1993. Frecuencia optima de riego en Aloe vera L.
Turrialba 43:261–267.
1. Fiume Z: Final report on the safety assessment of
Lecithin and
Hydrogenated Lecithin. Int J Toxicol 2001, 20 Suppl 1:21-45.
2. Sparr E, Wennerstrom H: Responding phospholipid membranes--interplay
between hydration and permeability.
Biophys J 2001, 81:1014-1028.
3. Lavery BA:
Skin care during radiotherapy: a survey of UK
practice.
Clin Oncol (R Coll Radiol ) 1995, 7:184-187.
4. Campbell J, Lane C: Developing a skin-care
protocol in radiotherapy. Prof Nurse
1996, 12:105-108.
5. Walker VA: Skin care during radiotherapy. Nurs Times 1982,
78:2068-2070.
6. Williams MS, Burk M, Loprinzi CL, Hill M,
Schomberg PJ, Nearhood
K, O'Fallon JR, Laurie JA, Shanahan TG, Moore RL,
Urias RE, Kuske
RR, Engel RE, Eggleston WD: Phase III double-blind
evaluation of
an aloe vera gel as a prophylactic agent for
radiation-induced
skin toxicity.
Int J Radiat Oncol Biol Phys 1996, 36:345-349.
7. Szumacher E, Wighton A, Franssen E, Chow E, Tsao
M, Ackerman I,
Andersson L, Kim J, Wojcicka A, Ung Y, Sixel K,
Hayter C: Phase II
study assessing the effectiveness of Biafine cream
as a prophylactic agent for radiation-induced acute skin toxicity to
the breast in women undergoing radiotherapy with
concomitant CMF chemotherapy. Int J
Radiat Oncol Biol Phys 2001,
51:81-86.
8. Fenig E, Brenner B, Katz A, Sulkes J, Lapidot M,
Schachter J, Malik H,
Sulkes A, Gutman H: Topical Biafine and Lipiderm for
the prevention of radiation dermatitis: a randomized prospective
trial. Oncol
Rep 2001, 8:305-309.
9. Fisher J, Scott C, Stevens R, Marconi B, Champion
L, Freedman GM,
Asrari F, Pilepich MV, Gagnon JD, Wong G: Randomized
phase III
study comparing Best Supportive Care to Biafine as a
prophylactic agent for radiation-induced skin toxicity for
women undergoing breast irradiation: Radiation
Therapy
Oncology Group (RTOG) 97-13. Int J Radiat Oncol Biol Phys 2000,
48:1307-1310.
10. Primavera G, Carrera M, Berardesca E, Pinnaro P,
Messina M, Arcangeli G: A double-blind,
vehicle-controlled clinical study to
evaluate the efficacy of MAS065D (XClair), a
hyaluronic
acid-based formulation, in the management of radiationinduced
dermatitis. Cutan Ocul Toxicol 2006,
25:165-171.
11. Bostrom A, Lindman H, Swartling C, Berne B,
Bergh J: Potent corticosteroid cream (mometasone furoate) significantly
reduces acute radiation dermatitis: results from a
doubleblind, randomized study. Radiother
Oncol 2001, 59:257-265.
12. Pommier P, Gomez F, Sunyach MP, D'Hombres A,
Carrie C, Montbarbon X: Phase III randomized trial of Calendula officinalis
compared with trolamine for the prevention of acute dermatitis during
irradiation for breast cancer. J Clin
Oncol 2004,
22:1447-1453.
13. Macmillan MS, Wells M, MacBride S, Raab GM,
Munro A, MacDougall
H: Randomized comparison of dry dressings versus
hydrogel
in management of radiation-induced moist
desquamation.
Int J Radiat Oncol Biol Phys 2007, 68:864-872.
14. Wells M, Macmillan M, Raab G, MacBride S, Bell
N, MacKinnon K,
MacDougall H, Samuel L, Munro A: Does aqueous or
sucralfate
cream affect the severity of erythematous radiation
skin
reactions? A randomised controlled trial. Radiother Oncol 2004,
73:153-162.
15. Ocular Research of Boston (ORB) I: Comparison
study of two
creams used in diabetic foot care. Boston, MA; 1997.
16. Korb DR, Greiner JV, Glonek T: The effects of
anionic and zwitterionic phospholipids on the tear film lipid layer. Adv Exp Med
Biol 2002, 506:495-499.
17. Oken MM, Creech RH, Tormey DC, Horton J, Davis
TE, McFadden
ET, Carbone PP: Toxicity and response criteria of
the Eastern
Cooperative Oncology Group. Am J Clin Oncol 1982, 5:649-655.
18. Muller K, Meineke V: Radiation-induced
alterations in cytokine
production by skin cells. Exp Hematol 2007, 35:96-104.
1. Bradley, D M, Swaim, S F, Stuart, S W
and Ryan, K A
(1995). The effects of topically
applied acemannan on the healing of wounds
with exposed bone; a pilot study. ACVS Poster
Session Abstract.
2. Cox, W I
(1988). Examining the immunological and haemopoeitic properties of an
immunostimulant. Veterinary Medicine, 424-428.
3. MacEwen, E G, Helfand, S C (1993).
Recent advances in the biologic therapy of
cancer. The Veterinary Compendium, 15:
909-912.
4. Sharma, J M., Karaca, K, Pertile, T (1994).
Virus induced immunosuppress-ion in chickens.
Poultry Science, 73: 1082-1086.
5. Tizzard, I (1992). Round table discussion
of the use of Equistim in horses. The Journal of
Equine Veterinary Science, 12: 209-214.
6. Vail, C D,
Nestved, A J, Rollins, J B, et
al (1990). The adjunct treatment of equine
respiratory disease complex with Proprionibacterium
acnes immunostimulant. The Journal
of Equine Veterinary Science, 10: 399-406.
Grindlay, D., and T. Reynolds. "The Aloe vera
Phenomenon: A Review of the Properties
and Modern Uses of the Leaf Parenchyma Gel.''
Journal of Ethnopharmacology 16
(1986):117 - 151.
Heggers, J. P., R. P. Pelley, and M. C. Robson.
``Beneficial Effects of Aloe in Wound
Healing.'' Phytotherapy Research 7 (1993):S48 - S52.
Koo, M. W. L. "Aloe vera: Antiulcer and
Antidiabetic Effects.'' Phytotherapy Research 8
(1994): 461 - 464.
Leung. A. "Aloe vera Update: A New Form
Questions Integrity of Old.'' Drug and Cosmetic
Industry (September 1985): 42 - 46.
Saito, H. "Purification of Active Substances of
Aloe arborescens Miller and their Biological
and Pharmacological Activity.'' Phytotherapy
Research 7 (1993): S14-S19.
1. Norris PG, Gange RW, Hawk JLM. Acute effects of
ultraviolet
radiation on the skin. In: Fitzpatrick
TB, Eisen AZ, Wolff K, Freedberg IM, editors.
Dermatology in general medicine. 4
th
ed. New York:
Plenum Medical, 1993: 1651-8.
2. Vichitpun V. Sunscreen efficacy of Aloe vera
comparing with standard sunscreen (5% Paraaminobenzoic acid). Thesis for Master
of science. Faculty of Medicine Chulalongkorn University,
1989.
3. Thanamittramanee S. Effects of Aloe vera (Linn.)
on vascular changes in burn model in rats.
Master’s thesis. Interdepartment of Physiology,
Graduate School, Chulalongkorn University, 1997.
4. Klein AD, Penneys NS. Aloe vera. J Am Acad
Derm 1988; 18: 714-20.
5. Farr PM, Diffey BL. Quantitative studies on
cutaneous erythema induced by UV radiation. Br J Derm
1970; 102: 405-17.
6. Kligman LH, Akin FJ, Kligman AM. Sunscreens
promote repair of ultraviolet radiation induced
dermal damage. J Invest Derm 1983; 81: 98-102.
7. Rovatti R, Brennan RJ. Experimental thermal burn.
Ind Med Surg 1959; 28: 364-7.
8. Loveman AB. Leaf of Aloe vera in treatment
of roentgen ray ulcers. Arch Derm Syp 1937; 36:
838-43.
9. Fine A, Samuel B. Cultivation and clinical
application of Aloe vera leaf. Radiology 1983; 3: 735-6.
10. Bracken WM, Cuppage F, Mcclaury RL, Kirwin C,
Klaassen CD. Treatment of HF acid burns. J Occup
Med 1985; 27: 735-9.
11. Rowe TD. Effect of fresh Aloe vera gel in the
treatment of third-degree Roentgen reaction on white
rats. Chem Abst 1940; 34: 7437.
12. Fujita K, Teradaira R, Nagatsu T. Bradykininase
activity of aloe vera extract. Biochem Pharm 1976;
25: 205-7.
Ahmed SM, Abdelgaleil SAM, 2005. Antifungal
activity of extracts and sesquiterpene
lactones from
Magnolia grandiflora L.
(Magnoliaceae). Int. J. Agric. Biol., 4: 638
– 642.
Alkhail AA, 2005. Antifungal activity of some
extracts against some plant pathogenic
fungi. Pak. J. Biol. Sci., 8 : 413 – 417.
Bajwa R, Akhtar N, Javiad A, 2001. Antifungal
activity of allelopathic plant extracts. I.
Effect of aqueous extracts of three
allelopathic Asteraceous species on growth
of
Aspergilli. Pak. J. Biol.
Sci., 4: 503 –
507.
Bajwa R, Shafique S, Anjum T, Shafique S,
2004. Antifungal activity of allelopathic
plant extracts IV: Growth response of
Alternaria alternata, Fusarium
monilifrome and Drechslera hawaiiensis to
aqueous extract of
Parthenium
hysterophorus L. Int. J. Agri. Biol., 6 : 511
- 516.
Bajwa R, Anjum T, Shafique S, Shafique S,
2006. Evaluation of antifungal activity of
Cicer arietinum L. Pak. J. Bot., 38 : 175 -
184.
Braga FG, Maria LM, Bouzada RL, Fabri, Matos
MO, Moreira FO, Scio E, Coimbra ES,
2007. Antileishmanial and antifungal
activity of plants used in traditional
medicine in Brazil.
J. Ethnopharmacol.,
111 : 396-402.
Bruneton J, 1993.
Pharmacognosie.
Phytochimie. Plantes médicinales, Tec
Doc, Paris p.
363.
Casian OR, Parvu M, Vlase L, Tamas M, 2007.
Antifungal activity of Aloe vera leaves.
Fitoterapia., 78 : 219 – 222.
Dubey NK, Tripathi P, Singh HB, 2000.
Prospects of some essential oils as
antifungal agents.
J. Med. Arom. Plant
Sci., 22: 350–354.
Falahati M, Tabrizib ON, Jahaniani F, 2005.
Anti dermatophyte activities of
Eucalyptuscamaldulensis in comparison with
griseofulvin. IJPT
4 : 80-83.
Grindlay D, Reynolds T, 1986. The A. vera
phenomenon: a review of the properties
and modern uses of the leaf parenchyma
gel. J. Ethnopharm., 16: 117–151.
Haller JJS, 1990. A drug for all seasons: medical
and pharm. history of Aloe. Bull. NY Acad.
Med., 66: 647–659.
Klein AD, Penneys NS, 1988. Aloe vera. J. Am.
Acad. Dermatol., 18: 714–720.
Levin H, Hazenfratz R, Friedman J, Palevitch D,
Perl M, 1988. Partial purification and some
properties of an antibacterial compound
from Aloe vera. Phytother. Res., 2: 67–69.
Manohar V, Ingram C, Gray J, Talpur NA,
Echard BW, Bagchi D, Preuss HG, 2001.
Antifungal activities of origanum oil
against
Candida albicans. Mol. Cell.
Biochem. 228: 111–117.
Macias FA, Galindoand JCG, Massanet GM,
1992.
Potential allelopathic activity of
several sesquiterpene lactone models.
Phytochem., 31: 1969-1977.
Morton JF, 1977. Aloe. In: Thomas, C.C. (Ed.),
Major Medicinal Plants-Botany, Culture
and Uses. Springfield, IL, pp. 46–50.
Newall CA, Anderson LA, Phillipson JD, 1996.
Herbal medicines., The Pharmaceutical
Press, London. p. 25.
Pavlou CG, Vakalounakis DJ, 2004. Biological
control of root and stem rot of greenhouse
cucumber, caused by Fusarium oxysporum
f. sp. radicis-cucumerinum, by lettuce soil
amendment. Crop Prot., 24: 135-140.
Reynolds T, 1985. The compounds in Aloe leaf
exudates: a review.
Bot. J. Linnean Soc,
90: 157–177.
Singh SP, Rao GP, Upadhyaya PP, 1998.
Fungitoxicity of essential oils of some
aromatic plants against sugarcane
pathogens. Sugar Cane, 2: 14–17.
Vyvyan JR, 2002. Allelochemicals as leads for
new herbicides and agrochemicals. Tetrahedron, 58:
1631 – 1646.
Alexander, D.J., 1998. Newcastle disease diagnosis,
Newcastle disease, 1 ed., Kluwar Academic pub,
st
Boston, pp: 98-160.
AOAC, 1995. Official Methods of Analysis. 16 ed,
th
Association of Official Analytical Chemists,
Arlington, Virginia, USA.
Arumugam, M.P. and B. Panda, 1970. Processing and
inspection of Poult. Ind. Vet. Res. Institute,
Izatnagar,
Uttar Pradesh, India.
B.I.S., 1992. Nutrient requirement for poultry.
Bureau of
Indian Standards, I.S. 13574.
Durrani, F.R., Mohammad Ismail, Asad Sultan, S.M.
Suhail, Naila Chand and Z. Durrani, 2006. Effect of
different levels of feed added turmeric (Curcuma
longa) on the performance of broiler chicks. J.
Agri.
Bio. Sci., 1: 9-11.
Emadi, M. and H. Kermanshahi, 2006. Effect of
turmeric
rhizome powder on performance and carcass
characteristics of broiler chickens. Int. J. Poult. Sci.,
5: 1069-1072.
Emadi, M., H. Kermanshahi and E. Maroufyan, 2007.
Effect of varying levels of turmeric rhizome powder
on some blood parameters of broiler chickens fed
corn-soybean meal based diets. Int. J. Poult. Sci.,
6:
345-348.
Folch, J., M. Lees and G.H.S. Stanley, 1957. A
simple
method for the isolation and purification of total
lipids from animal tissues. J. Bio. Chem., 226: 497-
507.
Jagadeeswaran, A., 2007. Exploration of growth
promoting and immunomodulating potentials of
indigenous drugs in broiler chicken immunized
against Newcastle viral disease. Ph.D., thesis
submitted to Tamil Nadu Veterinary and Animal
Sciences University, Chennai.
Namagirilakshmi, S., 2005. Turmeric (Curcuma longa)
as nutraceutical to improve broiler performance.
M.V.Sc., thesis submitted to Tamil Nadu Veterinary
and Animal Sciences University, Chennai, India.
Bettman AC: The tannic acid-silver nitrate treatment
of burns: A method of minimizing shock & toxemia
& shortening convalescence. Northwest Med.,
34:46-51, (Feb.) 1935.
Bettman AG: The rationale of the tannic acid-silver
nitrate treatment of burns. Jour. A.M.A., 108:1490-
1494, (May 1) 1937.
Collins CE: Alvagel as a therapeutic agent in the
treatment of roentgen and radium burns. Radiol. Rev. and
Chicago Med. Rec., 57:137-138, (June) 1935.
Collins CE; Collins, Creston: Roentgen dermatitis
treated with fresh whole leaf of Aloe vera. Am. Jour.
Roentgenal., 33:396-397, (Mar.) 1935.
Crewe JE: The external use of Aloes. Minn. Med.,
20:670-673. (Oct.) 1937.
Wright, Carroll S: Aloe vera in the treatment of
roentgen ulcers & telangiectasis. Jour. A.M.A., 106:1363-
1364, (Apr. 18) 1936.
1. WHO. Aloe vera, WHO monographs on selected
medicinal
plants 1: 295, 1999.
2. Capasso F, Borrelli F, Capasso R et al. Aloe and
its therapeutic
use. Phytother Res 12: 124-127, 1998.
3. Boudreau MD, Beland FA. An evaluation of the
biological and
toxicological properties of Aloe barbadensis
(Miller), Aloe vera.
J Environ Sci Health C 24: 103-154, 2006.
4. Stanic S. Anti-genotoxic effect of Aloe vera
gelon the mutagenic
effect of ethyl methanesulfonate. Arch Biol Sci 59:
223-226,
2007.
5. Kim HS, Lee BM. Inhibition of benzo[a]pyrene-DNA
adduct
formation by Aloe barbadensis Miller. Carcinogenesis
18: 771-
776, 1997.
6. Wasserman L, Avigad S, Beery E et al. The effect
of aloe emodin
on the proliferation of a new merkel carcinoma cell
line. Am J
Dermatopathol 24: 17-22, 2002.
7. Richardson J, Smithy JE, McIntyre M et al. Aloe
vera for
preventing radiation-induced skin reactions: a
systematic
literature review. Clin Oncol 17: 477-484, 2005.
8. Paes-Leme AA, Motta ES, De Mattos JCP et al.
Assessment of
Aloe vera
(L.) genotoxic potential on Escherichia coli and
plasmid DNA. J Ethnopharmacol 102: 197-201, 2005.
9. OECD. Mammalian bone marrow chromosome aberration
test.
OECD guideline for the testing of chemicals, 1997.
10. Topaktas M, Rencuzogullari E, Ila HB. In vivo
chromosomal
aberrations in bone marrow cells of rats treated
with Marshal.
Mutation Res 371: 259-264, 1996.
11. Evans HJ. Human peripheral blood lymphocytes for
the analysis
of chromosome aberrations in mutagen tests. In:
Kilbey BJ,
Legator M, Nichols W, Ramel C. eds. Handbook of
Mutagenicity
Test Procedures, 2nd ed. Elsevier Sciences
Publishers; 1984, pp.
405-427.
12. Perry PE, Thompson EJ. The methodology of sister
chromatid
exchanges. In: Kilbey BJ, Legator M, Nichols W,
Ramel C. eds.
Handbook of Mutagenicity Test Procedures, 2nd ed.
Elsevier
Sciences Publishers; 1984, pp. 495-529.
13. Albertini RJ, Anderson D, Douglas GR et al. IPCS
guidelines
for the monitoring of genotoxic effects of
carcinogens in
humans. Mutation Res 463: 111-172, 2000.
14. Speit G, Haupter S. On the mechanism of
differential Giemsa
staining of bromodeoxyuridine-substituted
chromosomes.
Hum Genet 70: 126-129, 1985.
15. Roncada T, Vicentini VE, Mantovani MS. Possible
modulating
actions of plant extracts on the chromosome breaking
activity
of MMC and Ara-C in human lymphocytes in vitro.
Toxicol In
Vitro 18: 617-622, 2004.
16. Mendelsohn ML. Antimutagenic effects in humans.
Mutation
Res 267: 257-264, 1992.
17. Paz-y-Mino C, Bustamante G, Sanchez ME et al.
Cytogenetic
monitoring in a population occupationally exposed to
pesticides in Ecuador. Environ Health Perspective
110: 1077-
1080, 2002.
18. Mace J ML, Daskal Y, Wray W. Scanning-electron
microscopy
of chromosome aberrations. Mutation Res 52: 199-206,
1978.
19. Fenech M. The in vitro micronucleus technique.
Mutation Res
455: 81-95, 2000.
20. Kirsch-Volders M, Sofuni T, Aardemac M. Report
from the in
vitro micronucleus assay working group. Mutation Res
540:
153-163, 2003.
21. Redbook, Toxicological principles for the safety
assessment of
food ingredients, bacterial reverse mutation test.
Office of Food
Additive Safety, 2000.
22. Maron DM, Ames BN. Revised method for the
Salmonella
mutagenicity test. Mutation Res 113: 173-215, 1983.
23. Vogler BK, Ernst E. Aloe vera: a systematic
review of its clinical
effectiveness. Br J Gen Pract 49: 823-828, 1999.
24. Heidemann A, Volkner W, Mengs U. Genotoxicity of
aloeemodin in vitro and in vivo. Mutat Res 367:
123-133, 1996.
25. Liberman DF, Schaefer FL, Fink RC et al.
Mutagenicity of
islandicin and chrysophanol in the
Salmonella/microsome
system. Appl Environ Microbiol 40: 476-479, 1980.
26. NTP, National Toxicology Program. Toxicology and
carcinogenesis studies of emodin (CAS NO. 518-82-1)
feed
studies in F344/N rats and B6C3F1 mice. Natl Toxicol
Program
Tech Rep Ser 493: 1-278, 2001.
27. Westendorf J, Marquardt H, Poginsky B et al.
Genotoxicity of
naturally occurring hydroxyanthraquinones. Mutation
Res 240:
1-12, 1990.
28. Heidemann A, Miltenburger HG, Mengs U. The
genotoxicity
status of senna. Pharmacology 47: 178-186, 1993.
29. Mengs U, Schuler D, Marshall RR. No induction of
chromosomal aberrations in Chinese hamster ovary
cells by
chrysophanol. Mutation Res 492: 69-72, 2001.
30. Mueller SO, Stopper H, Dekant W.
Biotransformation of the
anthraquinones emodin and chrysophanol by cytochrome
P450
enzymes. Bioactivation to genotoxic metabolites.
Drug Metab
Dispos 26: 540-546, 1998.
31. Mueller SO, Stopper H. Characterization of the
genotoxicity of
anthraquinones in mammalian cells. Biochim Biophys
Acta
1428: 406-414, 1999.
32. Burden DA, Osheroff N. Mechanism of action of
eukaryotic
topoisomerase II and drugs targeted to the enzyme.
Biochim
Biophys Acta 1400: 139-154, 1998.
33. Lynch A, Harvey J, Aylott M et al.
Investigations into the
concept of a threshold for topoisomerase
inhibitor-induced
clastogenicity. Mutagenesis. 18: 345-353, 2003.
34. Parry O, Matambo C. Some pharmacological actions
of aloe
extracts and Cassia abbreviata on rats and mice.
Cent Afr J Med
38: 409-414, 1992.
35. Furukawa F, Nishikawa A, Chihara T et al.
Chemopreventive
effects of Aloe arborescens on N-nitrosobis
(2-oxopropyl)
amine-induced pancreatic carcinogenesis in hamsters.
Cancer
Lett 178: 117-122, 2002.
36. Harris C, Pierce K, King G et al. Efficacy of
acemannan in
treatment of canine and feline spontaneous
neoplasms. Mol
Biother 3: 207-213, 1991.
37. Shamaan NA, Kadir KA, Rahmat A et al. Vitamin C
and aloe
vera supplementation protects from chemical
hepatocarcinogenesis in the rat. Nutrition 14:
846-852, 1998.
38. Yoo EJ, Lee BM. Chemopreventive effects of aloe
against
genotoxicity induced by benzo[a]pyrene. J Toxicol
Environ
Health A 68: 1841-1860, 2005.
39. Akev N,Turkay G, Can A et al. Tumour preventive
effect of Aloe
vera leaf pulp lectin (Aloctin I) on Ehrlich ascites
tumours in
mice. Phytother Res 21: 1070-1075, 2007.
40. Mengs U, Krumbiegel G, Volkner W. Lack of emodin
genotoxicity in the mouse micronucleus assay.
Mutation Res
393: 289-293, 1997.
41. Pecere T, Gazzola MV, Mucignat C et al.
Aloe-emodin is a new
type of anticancer agent with selective activity
against
neuroectodermal tumors. Cancer Res 60: 2800-2804,
2000.
42. Lee HZ. Protein kinase C involvement in
aloe-emodin- and
emodin-induced apoptosis in lung carcinoma cell. Br
J
Pharmacol 134: 1093-1103, 2001.
43. Kuo PL, Lin TC, Lin CC. The antiproliferative
activity of aloeemodin is through p53-dependent and p21-dependent
apoptotic pathway in human hepatoma cell lines. Life
Sci 71:
1879-1892, 2002.
44. Epel D. The effects of carbon monoxide
inhibition of ATP level
and the date of mitosis in the sea urchin egg. J
Cell Biol 17: 315-
319, 1963.
45. Jain AK, Andsorbhoy RK. Cytogenetical studies on
the effects
of some chlorinated pesticides. III: Concluding
remarks.
Cytologia 53: 427-436, 1988.
46. Armstrong
MJ, Bean CL, Galloway SM. A quantitative
assessment of cytotoxicity associated with
chromosomal
aberration detection in Chinese hamster ovary cells.
Mutation
Res 265: 45-60, 1992.
47. Hilliard CA,
Armstrong MJ, Bradt CI et al. Chromosome
aberrations in vitro related to cytotoxicity of
non-mutagenic
chemicals and metabolic poisons. Environ Mol Mutagen
31:
316-326, 1998.
48. Galloway SM, Miller JE, Armstrong MJ et al. DNA
synthesis
inhibition as an indirect mechanism of chromosome
aberrations: comparison of DNA-reactive and
non-DNAreactive clastogens. Mutation Res 400: 169-186, 1998.
49. Vock EH, Lutz WK, Hormes P et al. Discrimination
between
genotoxicity and cytotoxicity in the induction of
DNA doublestrand breaks in cells treated with etoposide, melphalan,
cisplatin, potassium cyanide, Triton X-100 and
γ-irradiation.
Mutation Res 413: 83-94, 1998.
50. Kirkland DJ, Muller L. Interpretation of the
biological relevance
of genotoxicity test results: the importance of
thresholds.
Mutation Res 464: 137-147, 2000.
51. Madle S, Beek B, Nowak C. Zum Verständnis von
Chromosomenmutationstests an Somazellen. In: Fahrig
R. ed.
Mutationsforschung und Genetische Toxicologie.
Wissenschaftliche Buchgesellschaft Publishers; 1993,
pp. 224-
242.
52. Nath D, Sethi N, Singh RK et al. Commonly used
Indian
abortifacient plants with special reference to their
teratologic
effects in rats. J Ethnopharmacol 36: 147-154, 1992.
1 Bailey CJ, Day C. Traditional plant medicines as
treatments for
diabetes. Diabetes Care 1989; 12: 553–64.
2 Doucet J, Chassagne P, Trivalle C, et al.
Drug-drug interactions
related to hospital admissions in older adults: a
prospective study of
1000 patients. J Am Geriatr Soc 1996; 44: 944–48.
3 Fugh-Berman A, Cott JM. Dietary supplements and
natural
products as psychotherapeutic agents. Psychosom Med
1999; 61:
712–28.
4 Cott JM, Fugh-Berman A. Is St John’s Wort
(Hypericum perforatum)
an effective antidepressant? J Nerv Ment Dis 1998;
186: 500–01.
5 Deahl M. Betel nut-induced extrapyramidal
syndrome: an unusual
drug interaction. Mov Disord 1989; 4: 330–33.
6 Taylor RFH, Al-Jarad N, John LME. Betel-nut
chewing and asthma.
Lancet 1992; 339: 1134–36.
7 Hakas JF. Topical capsaicin induces cough in
patient receiving ACE
inhibitor. Ann Allergy 1990; 65: 322.
8 Bouraoui A, Toum A, Bouchoucha S, et al. Influence
de
l’alimentation épicéé et piquante sur l’absorption
de la théophylline.
Thérapie 1986; 41: 467–71.
9 Tam LS, Chan TYK, Leung WK, Critchley JAJH.
Warfarin
interactions with Chinese traditional medicines;
danshen and methyl
salicylate medicated oil. Aust NZ J Med 1995; 25:
257.
10 Yu CM, Chan JCN, Sanderson JE. Chinese herbs and
warfarin
potentiation by ‘danshen’. J Intern Med 1997; 241:
337–39.
11 Izzat MB, Yim APC, El-Zufari MH. A taste of
Chinese medicine.
Ann Thorac Surg 1998; 66: 941–42.
12 Chan K, Lo AC, Yeung JH, Woo KS. The effects of
danshen (Salvia
miltiorrhiza) on warfarin pharmacodynamics and
pharmacokinetics of
warfarin enantiomers in rats. J Pharm Pharmacol
1995; 47: 402–06.
13 Cheng TO. Warfarin danshen interaction. Ann
Thorac Surg 1999;
67: 892–96.
14 Shaw D, Leon C, Kolev S, Murray V. Traditional
remedies and food
supplements: a five year toxicological study
(1991–1995). Drug Saf
1997; 17: 342–56.
15 Page RL, Lawrence JD. Potentiation of warfarin by
dong quai.
Pharmacotherapy 1999; 19: 870–76.
16 Ellis GR, Stephens MR. Untitled (photograph and
brief case report).
BMJ 1999; 319: 650.
17 McRae S. Elevated serum digoxin levels in a
patient taking digoxin
and Siberian ginseng. Can Med Assoc J 1996; 155:
293–95.
18 De Smet PAGM, D’Arcy PF. Drug interactions with
herbal and
other non-toxic remedies. In: D’Arcy PF, McElnay JC,
Welling PG, eds. Mechanisms of drug interactions.
Berlin:
Springer-Verlag, 1996.
19 Burnham BE. Garlic as a possible risk for
postoperative bleeding.
Plast Reconstruc Surg 1995; 95: 213.
20 German K, Kumar U, Blackford HN. Garlic and the
risk of TURP
bleeding. Br J Urol 1995; 76: 518.
21 Rose KD, Croissant PD, Parliament CF, Levin MB.
Spontaneous
spinal epidural hematoma with associated platelet
dysfunction from
excessive garlic consumption: a case report.
Neurosurgery 1990; 26:
880–82.
22 Rosenblatt M, Mindel J. Spontaneous hyphema
associated with
ingestion of ginkgo biloba extract. N Engl J Med
1997; 336: 1108.
23 Lamant V, Mauco G, Braquet P, Chap H,
Douste-Blazy L.
Inhibition of the metabolism of platelet activating
factor (PAFacether) by three specific antagonists from Ginkgo biloba. Biochem
Pharmacol 1987; 36: 2749–52.
24 Chung KF, McCusker M, Page CP, et al. Effect of a
ginkgolide
mixture (BN 52063) in antagonizing skin and platelet
responses to
platelet activating factor in man. Lancet 1987; i:
248–50.
25 Rowin J, Lewis SL. Spontaneous bilateral subdural
hematomas
associated with chronic Ginkgo biloba ingestion.
Neurology 1996; 46:
1775–76.
26 Vale S. Subarachnoid haemorrhage associated with
ginkgo biloba.
Lancet 1998; 352: 36.
27 Gilbert GJ. Ginkgo biloba. Neurology 1997; 48:
1137.
28 Matthews MK. Association of Ginkgo biloba with
intracerebral
hemorrhage. Neurology 1998; 50: 1933.
29 Janetzky K, Morreale AP. Probable interaction
between warfarin and
ginseng. Am J Health Syst Pharm 1997; 54: 692–93.
30 Zhu M, Chan KW, Ng LS, et al. Possible influences
of ginseng on
the pharmacokinetics and pharmacodynamics of
warfarin in rats.
J Pharm Pharmacol 1999; 51: 175–80.
31 Shader RI, Greenblatt DJ. Phenelzine and the
dream machine—
ramblings and reflections. J Clin Psychopharmacol
1985; 5: 65.
32 Jones BD, Runikis AM. Interaction of ginseng with
phenelzine.
J Clin Psychopharmacol 1987; 7: 201–02.
33 Lee FC, Ko JH, Park JK, Lee JS. Effects of Panax
ginseng on blood
alcohol clearance in man. Clin Exp Pharmacol Physiol
1987; 14: 543–46.
34 Aslam M, Stockley IH. Interaction between curry
ingredient (karela)
and drug (chlorpropamide). Lancet 1979; i: 607.
35 Leatherdale BA, Panesar RK, Singh G, et al. Improvement
in
glucose tolerance due to Momordica charantia
(karela). BMJ 1981;
282: 1823–24.
36 Chen M-F, Shimada F, Kato H, et al. Effect of
oral administration
of glycyrrhizin on the pharmacokinetics of
prednisolone. Endocrinol
Jpn 1991; 38: 167–75.
37 Chen M-F, Shimada F, Kato H, et al. Effect of
glycyrrhizin on the
pharmacokinetics of prednisolone following low
dosage of
prednisolone hemisuccinate. Endocrinol Jpn 1990; 37:
331–41.
38 Teelucksingh S, Mackie ADR, Burt D, et al.
Potentiation of
hydrocortisone activity in skin by glycyrrhetinic
acid. Lancet 1990;
335: 1060–63.
39 De Klerk GJ, Nieuwenhuis MG, Beutle JJ.
Hypokalaemia and
hypertension associated with use of liquorice
flavoured chewing
gum. BMJ 1997; 314: 731–32.
40 Bernardi M, D’Intino PE, Trevisani F, et al.
Effects of prolonged graded
doses of licorice by healthy volunteers. Life Sci
1994; 55: 863–72.
41 Perlman BB. Interaction between lithium salts and
ispaghula husk.
Lancet 1990; 335: 416.
42 Gordon JB. SSRIs and St John’s wort: possible toxicity?
Am Fam
Phys 1998; 57: 950.
43 Demott K. St John’s wort tied to serotonin
syndrome. Clin Psychiatry
News 1998; 26: 28.
44 Lantz MS, Buchalter E, Giambanco V. St John’s
Wort and
antidepressant drug interactions in the elderly. J
Geriatr Psychiatr
Neurol 1999; 12: 7–10.
45 Nebel A, Schneider BJ, Baker RK, Kroll DJ.
Potential metabolic
interaction between St John’s Wort and theophylline.
Ann Pharmacother 1999; 33: 502.
46 Johne A, Brockmöller J, Bauer S, et al.
Pharmacokinetic interaction
of digoxin with an herbal extract from St John’s
wort (Hypericum
perforatum). Clin Pharmacol Ther 1999; 66: 338–45.
47 Ernst E. Second thoughts about safety of St
John’s wort. Lancet
1999; 354: 2014–15.
48 Maurer A, Johne A, Bauer S, et al. Interaction of
St John’s wort
extract with phenprocoumon. Eur J Clin Pharmacol
1999; 55: A22.
49 Bon S, Hartmann K, Kuhn M. Schweitzer
Apothekerzeitung 1999; 16:
535–36.
50 Homma M, Oka K, Ikeshima K, et al. Different
effects of traditional
Chinese medicines containing similar herbal
constituents on
prednisolone pharmacokinetics. J Pharm Pharmacol
1995; 47:
687–92.
51 Dandekar UP, Chandra RS, Dalvi S, et al. Analysis
of clinically
important interaction between phenytoin and
Shankhapushpi, an
Ayurvedic preparation. J Ethnopharm 1992; 35:
285–88.
52 Mustapha A, Yakasai IA, Aguye IA. Effect of
Tamarindus indica L on
the bioavailability of aspirin in healthy human
volunteers. Eur Drug
Metab Pharmacokinet 1996; 21: 223–26.
53 Bos R, Woerdenberg HJ, De Smet PAGM, Scheffer
JJC. Valeriana
species. In: De Smet PAGM, Keller K, Hansel R,
Chandler RF, eds.
Adverse effects of herbal drugs, vol 3. Berlin:
Springer, 1997:
165–80.
54 Lacombiez L, Bensimon G, Isnard F, et al. Effect
of yohimbine on
blood pressure in patients with depression and orthostatic
hypertension induced by clomipramine. Clin Pharmacol
Ther 1989;
45: 241–51.
55 De Smet PAGM. Yohimbe alkaloids—general
discussion. In:
De Smet PAGM, Keller K, Hansel R. Chandler RF, eds.
Adverse effects of herbal drugs, volume 3. Berlin:
Springer, 1997:
181–206.
56 But PP-H. Herbal poisoning caused by adulterants
or erroneous
substitutes. J Trop Med Hyg 1994; 97: 371–74.
57 Koren G, Randor S, Martin S, Danneman D. Maternal
ginseng use
associated with neonatal androgenization. JAMA 1990;
264:
2866.
58 Awang DVC. Maternal use of ginseng and neonatal
androgenization.
JAMA 1991; 266: 363.
59 Huang WF, Wen K-C, Hsiao M-L. Adulteration by
synthetic
therapeutic substances of traditional Chinese
medicines in Taiwan.
J Clin Pharmacol 1997; 37: 344–50.
60 Gertner E, Marshall PS, Filandrinos D, et al.
Complications
resulting from the use of Chinese herbal medications
containing undeclared prescription drugs. Arthritis
Rheum 1995;
38: 614–17.
61 Vander Stricht BI, Parvais OE, Vanhaelen-Fastre
RJ. Remedies may
contain cocktail of active drugs. BMJ 1994; 308:
1162.
62 Ko RJ. Adulterants in Asian patent medicines. N
Engl J Med 1998;
339: 847.
63 Eisenberg DM, Davis RB, Ettner SL, et al. Trends
in alternative
medicine use in the United States, 1990–97. JAMA
1998; 280:
1569–75.
64 Barnes J, Mills SY, Abbott NC, et al. Different
standards for
reporting ADRs to herbal remedies and conventional
OTC
medicines: face to face interviews with 515 users of herbal remedies.
Br J Clin Pharmacol 1998; 45: 496–500.
65 Westendorf J. Anthranoid derivatives—general
discussion. In:
De Smet PAGM, Keller K, Hansel R, Chandler RF.
Adverse effects
of herbal drugs, vol 2: 105–08.
1. Al-Ahmed, F.A., E.S. El-Denshary and M. Zaki,
1989. Interaction between diazepam and oral
antidiabetic agents
on serum glucose, insulin and
chromium
levels in rats.
Biol. Sci. Rep., 9:
347-350.
2. Coulston, L and P. Dandona, 1980. Insulin-like
effect
of zinc on
adipocytes. Diabetes, 29:
665-667.
3. Lozak, A., K. Soltyk. and P. Ostapczuk. 2002.
Determination of selected trace
elements in herbs
and their infusions. Sci. Total Environ, 289: 33-40.
4. Rajasekaran, S., K. Sivagnanam and S.
Subramanian. 2005. Mineral contents of Aloe vera
leaf gel and their role on Streptozotocin induced
diabetic rats. Biol. Trace Elements, 107: 1-11.
5. Rajurkar, N.S. and M.M. Damame, 1998. Mineral
content of
medicinal plants used in the treatment
of disease resulting from tract disorders. Appl.
Radiat. Isot., 49: 773-776.
6. Underwood, E.J., 1977. Trace elements in human
and animal nutrition, 4 ed., Academic, New York.
th
7. Underwood, M.K., M.J. Rosentha, S. and S. Hong,
1986. Trace
elements in human and animal
nutrition, Academic, New York.
8. Wang, J., V.G. Yuen and J.H. McNeil, 2001.
Effect of
vanadium on insulin sensitivity and
appetite. Metabolism, 50: 667-673.
1. — ALPONAT A., LAKSHMINARASAPPA S.R., YAVUZ N.,
GOH
P.M. : Prevention of adhesions by Seprafilm, an
absorbable adhesion
barrier : an incisional hernia model in rats. Am
Surg., 1997, 63, 818-
9.
2. — AVIJGAN M. : Phytotherapy: an alternative
treatment for non-healing ulcers. J. Wound Care, 2004, 13, 157-158.
3. — BAIGRE R., LAMONT P., DALLMAN M., MORRIS, P. :
The
release of interleukin-1 precedes that of IL-6 in
patients undergoing
major surgery. Lymphokine Res., 1991, 10, 253-256.
4. — BAXTER G.M., BROOWE T.E., MOORE J.N. :
Abdominal adhesions after small intestinal surgery in the horse. Vet. Surg.,
1989, 18,
409-411.
5. — BOTHIN C., OKADA M., MIDTVEDT T., PERBECK L. :
The
intestinal flora influences adhesion formation
around surgical anastomoses. Br. J. Surg., 2001, 88, 143-145.
6. — BUCKMAN R.F., WOODS M., SARGENT L., GERVIN A.S.
: A
unifying pathogenetic mechanism in the etiology of
intraperitoneal
adhesions. J. Surg. Res., 1976, 20, 1-5.
7. — CHEONG Y.C., LAIRD S.M., SHELTON J.B., LEDGER
W.L., LI
T.C., COOKE I.D. : The correlation of adhesions and
peritoneal fluid
cytokine concentrations: a pilot study. Hum Reprod.,
2002, 17, 1039-
1045.
8. — COSTAIN D.J., KENNEDY R., CIONA C., MC ALISTER
V.C. :
Prevention of postsurgical adhesions with
N,O-carboxymethyl chitosan : examination of the most efficacious preparation
and the effect
of N,O-carboxymethyl chitosan healing. Surgery,
1997, 121, 314-
319.
9. — CROWE D.T., BJORLING D.E. : Peritoneum and
peritoneal cavity.
In : D. Slatter (ed.) : Textbook of Small Animal
Surgery, W.B.
Saunders Company, London, 1993, 407-430.
10. — DAVIS R.H., KABBANI J.M., MARO N.P. : Aloe
vera and wound
healing. J. Am. Pediatr. Med. Assoc., 1987, 77,
165-169.
11. — DAVIS R.H., LEITNER M.G., RUSSO, J.M. : Aloe
vera : A natural
approach for treating wounds, edema and pain in
diabetes. J. Am.
Pediatr. Med. Assoc., 1988, 78, 60-68.
12. — DARVILLE T., TABOR D.R., THEUS S.A., JACOBS
R.F. : Surface
matrix binding alters murine peritoneal mononuclear
phagocyte
TNF-alpha and IL-6 induction. Immunol. Invest.,
1992, 21, 539-552.
13. — DUANSAK D., SOMBOONWONG J., PATUMRAJ S. :
Effects of
Aloe Vera on leukocyte adhesion and TNF-alpha and
IL-6 levels in
burn wounded rats. Clin. Hemorheol. Microcirc.,
2003, 29, 239-246.
14. — ELKINS T.E., BURY R.J., RITTER J.I. : Adhesion
prevention by
solutions of sodium carboxymethyl cellulose in rat.
Fertil. Steril.,
1984, 41, 926-928.
15. — ELLIS H. : The causes and prevention of
intestinal adhesions. Br. J.
Surg., 1982, 69, 241-243.
16. — ELLIS H. : The cause and prevention of
post-operative intraperitoneal adhesions. Surg. Gynecol. Obstet., 1971, 133,
497-511.
17. — EVANS D.M., MC AREE K., GUYTON D.P. : Dose
dependency and
wound healing aspects of the use of tissue
plasminogen activator in
the prevention of intra-abdominal adhesions. Am. J.
Surg., 1993,
165, 229- 232.
18. — GALILI Y., ABRAHAM R.B., RABAU M., KLAUSNER
J., KLU- GER Y. : Reduction of surgery induced peritoneal adhesions by
methylene blue. Am. J. Surg., 1998, 175, 30-32.
19. — GRINDLAY, G., REYNOLDS, T. : The Aloe vera
phenomenon. A
review of the properties and modern uses of the leaf
parenchyma gel.
J. Ethnopharmacol., 1986 , 16, 117-151.
20. — HAU TPAYNE W.D., SIMMONS R.L. : Fibrinolytic activity
of the
peritoneum during experimental peritonitis. Surg.
Gynecol. Obstet.,
1979, 148, 415-418.
21. — HEGGARS J.P., PELLEY R.P., ROBSON M.C. :
Beneficial effects
of Aloe in wound healing. J. Phytotherapy Res.,
1993, 7, 48-52.
22. — HEGGERS J.P., KUCUKCELEBI A., STABENAU C.J. :
Wound
healing effects of Aloe vera gel and other topical antimicrobial
agents on rat skin. J. Phytotherapy. Res., 1995, 9,
455-457.
23. — HELLEBREKERS B., TRIMBOS-KEMPER T., TRIMBOS
J.,
EMEIS J., KOOISTRA T. : Use of fibrinolytic agents
in the prevention of post-operative adhesion formation. Fertil. Steril., 2000,
74,
203-212.
24. — KAGOMA P., BURGER S.N., SEIFTER E., LEVENSON
S.M.,
ACHILLES A. : The effect of vitamin E on
experimentally induced
peritoneal adhesions in mice. Arch. Surg., 1985,
120, 949-951.
25. — KENNEDY R., COSTAIN D.J., MC ALISTER V.C. :
Prevention of
experimental post-operative peritoneal adhesions by
N,O-carboxymethyl chitosan. Surgery, 1996, 120, 866-870.
26. — LANGMEAD L., MAKINS R.J., RAMPTON D.S. : Antiinflamatory
effects of Aloe vera gel in human colorectal mucosa
in vitro. Aliment.
Pharmacol. Ther., 2004, 19, 521-27.
27. — LOWRY S. : Cytokine mediators of immunity and
inflammation.
Arch. Surg., 1993, 128, 1235-1241.
28. — MENZIES D, ELLIS H. : Intestinal obstruction
from adhesions. How
big is the problem? Ann. R. Coll. Surg. Engl., 1990,
72, 60-63.
29. — MILLER M.B., KOLTAI P.J. : Treatment of
experimental frostbite
with pentoxifylline and Aloe vera cream. Arch.
Otolaryngol. Head
Neck Surg., 1995, 121, 678-680.
30. — MONTZ F.J., FOWLER J., WOLFF A.J., LACEY S.M.,
MOHLER
M. : The ability of recombinant tissue plasminogen
activator to inhibit post-radical pelvic surgery adhesions in the dog model.
Am. J.
Obstet. Gynecol., 1991, 165, 1539-1541.
31. — NAGLER A., RIVKIND A.I., RAPHAEL J., SCHAFFER
F.L.,
GENINA O. : Halofuginone-an inhibitor of collagen
type I synthesis-prevents post-operative formation of abdominal adhesions. Ann.
Surg., 1998, 227, 575-82.
32. — NAIR S., BHAT I., AURORA A. : Role of
proteolytic enzyme in the
prevention of post-operative intraperitoneal
adhesions. Arch. Surg.,
1974, 108, 849-853.
33. — NAGELSCHMIDT M., SAAD S. : Influence of
polyethylene glycol
4000 and dextran 70 on adhesion formation in rats.
J. Surg. Res.,
1997, 67, 113-118.
34. — OZOGUL Y., BAYKAL A., ONAT D., RENDA N., SAYEK
I. : An
experimental study of the effect of Aprotinin on
intestinal adhesion
formation. Am. J. Surg., 1998, 175, 137-141.
35. — ROBERTS D.B., TRAVIS E.L. :
Acemannan-containing wound
dressing gel reduces induced skin reactions in C3H
mice. Int. J.
Radiat. Oncol. Biol. Phys., 1995, 32, 1047-1042.
36. — TREUTNER K.H., SCHUMPELICK V. : Adhesion
prevention.Wish
and reality. Chirurg., 2000, 71, 510-517.
37. — TSUKADA K., KATOH H., SHIOJIMA M., SUZUKI T.,
TAKENOSHITA S., NAGAMACHI, Y. : Concentrations of cytokines in peritoneal fluid
after abdominal surgery. Eur. J. Surg., 1993, 159, 475-
479.
38. — VAN GOOR H., DE GRAFF J.S., GROND J. :
Fibrinolytic activity
in the abdominal cavity of rats with faecal peritonitis.
Br. J. Surg.,
1994, 81, 1046-1049.
39. — VAZQUEZ B., AVILA G., SEGURA D., ESCALANTE B.
:
Antiinflammatory activity of extracts from Aloe vera
gel. J.
Ethnopharmacol., 1996, 55, 69-75.
40. — VERMEULEN H., UBBINK D., GOESSENS A., LEGEMATE
D. :
Dressing and topical agent for surgical wounds
healing by secundery
intention. Cochrane Syst. Rev. 2004, CD003554.
41. — VIPOND M.N., WHAWELL S.A., THOMPSON J.N.,
DUDLEY
H.A. : Peritoneal fibrinolytic activity and
intraabdominal adhesions.
Lancet, 1990, 335, 1120-1122.
42. — WEIBEL M.A., MAJNO G. : Peritoneal adhesions
and their relation
to abdominal surgery. A postmortem study. Am. J.
Surg., 1973, 126,
345-349.
1. Parkin DM, Bray F, Ferlay J, et al. Global cancer
statistics, 2002.
CA Cancer J Clin 2005;55:74–108.
2. Ziegler RG, Hoover RN, Pike MC, et al. Migration
patterns and
breast cancer risk in Asian-American women. J Natl
Cancer Inst
1993;85:1819–27.
3. Haenszel W, Kurihara M. Studies of Japanese
migrants. I.
Mortality from cancer and other diseases among
Japanese in
the United States. J Natl Cancer Inst 1968;40:43–68.
4. Wong AH, Gottesman II, Petronis A. Phenotypic
differences in
genetically identical organisms: the epigenetic
perspective.
[Special issue] Hum Mol Genet 2005;14(1):R11–8.
5. Kolonel LN, Altshuler D, Henderson BE. The
multiethnic cohort
study: exploring genes, lifestyle and cancer risk.
Nat Rev Cancer
2004;4:519–27.
6. Sharma PV. Charaka samhita. Varanasi: Choukhamba
Orientalia;
1981.
7. Murthy KRS. Sushruta samhita (700 BC). Varanasi:
Choukhamba
Orientalia; 2005.
8. Chopra A, Doiphode VV. Ayurvedic medicine, core
concept,
therapeutic principles, and current relevance.
Complemet Altern
Med 2002;86:75–89.
9. Murthy KRS. Astanga-Hridaya of Vagbhata.
Varanasi:
Choukhamba orientalia; 2005.
10. Murthy KRS. Sarangadhara samhita. Varanasi:
Chaukambha
Orientalia; 2001.
11. Murthy KRS. Bhavaprakasa of Bhavamisra.
Varanasi:
Chaukambha Krishnadas Academy; 2001.
12. Dash B, Kashyap L. Diagnosis and treatment of
Galaganda,
Gandamala, apaci, granthi and arbuda. New Delhi:
Concept
Publishing Company; 1987.
13. Joseph CD, Praveenkumar V, Kuttan G, et al.
Myeloprotective
effect of a non-toxic indigenous preparation
rasayana in cancer
patients receiving chemotherapy and radiation
therapy. A pilot
study. J Exp Clin Cancer Res 1999;18:325–9.
14. Rekha PS, Kuttan G, Kuttan R. Antioxidant
activity of Brahma
rasayana. Indian J Exp Biol 2001;39:447–52.
15. Scartezzini P, Speroni E. Review on some plants
of Indian
traditional medicine with antioxidant activity. J
Ethnopharmacol
2000;71:23–43.
16. Rege NN, Thatte UM, Dahanukar SA. Adaptogenic
properties of
six rasayana herbs used in ayurvedic medicine.
Phytother Res
1999;13:275–91.
17. Diwanay S, Chitre D, Patwardhan B.
Immunoprotection by
botanical drugs in cancer chemotherapy. J
Ethnopharmacol 2004;
90:49–55.
18. Russo A, Izzo AA, Cardile V, et al. Indian
medicinal plants as
antiradicals and DNA cleavage protectors.
Phytomedicine 2001;8:
125–32.
19. Li X, Ding X, Adrian TE. Arsenic trioxide causes
redistribution of
cell cycle, caspase activation, and GADD expression
in human
colonic, breast, and pancreatic cancer cells. Cancer
Invest 2004;22:
389–400.
20. Lam HK, Li K, Chik KW, et al. Arsenic trioxide
mediates
intrinsic and extrinsic pathways of apoptosis and
cell cycle arrest
in acute megakaryocytic leukemia. Int J Oncol
2005;27:537–
45.
21. Sastry JLN. Introduction to oncology, cancer in
ayurveda.
Varanasi: Chaukhambha Orientalia; 2001.
22. Balachandran P, Govindarajan R. Cancer—an
ayurvedic perspective. Pharmacol Res 2005;51:19–30.
23. Singh RH. An assessment of the ayurvedic concept
of cancer and a
new paradigm of anticancer treatment in ayurveda. J
Altern
Complement Med 2002;8:609–14.
24. Reddy S, Aggarwal BB. Curcumin is a
non-competitive and
selective inhibitor of phosphorylase kinase. FEBS
Lett 1994;341:
19–22.
25. Singh S, Aggarwal BB. Activation of
transcription factor NFkappa B is suppressed by curcumin (diferuloylmethane)
[corrected]. J Biol Chem 1995;270:24995–5000.
26. Natarajan K, Singh S, Burke TR Jr, et al.
Caffeic acid phenethyl
ester is a potent and specific inhibitor of
activation of nuclear
transcription factor NF-kappa B. Proc Natl Acad Sci
U S A 1996;
93:9090–5.
27. Singh S, Natarajan K, Aggarwal BB. Capsaicin
(8-methyl-Nvanillyl-6-nonenamide) is a potent inhibitor of nuclear
transcription factor-kappa B activation by diverse agents. J Immunol 1996;
157:4412–20.
28. Chaturvedi MM, Kumar A, Darnay BG, et al.
Sanguinarine
(pseudochelerythrine) is a potent inhibitor of
NF-kappaB
activation, IkappaBalpha phosphorylation, and
degradation. J
Biol Chem 1997;272:30129–34.
29. Kumar A, Dhawan S, Aggarwal BB. Emodin
(3-methyl-1,6,8-
trihydroxyanthraquinone) inhibits TNF-induced
NF-kappaB
activation, IkappaB degradation, and expression of
cell surface
adhesion proteins in human vascular endothelial
cells. Oncogene
1998;17:913–8.
30. Kumar A, Dhawan S, Hardegen NJ, et al. Curcumin
(diferuloylmethane) inhibition of tumor necrosis factor (TNF)-
mediated adhesion of monocytes to endothelial cells
by suppression of cell surface expression of adhesion molecules and of
nuclear factor-kappaB activation. Biochem Pharmacol
1998;55:
775–83.
31. Manna SK, Mukhopadhyay A, Van NT, et al.
Silymarin
suppresses TNF-induced activation of NF-kappa B,
c-Jun Nterminal kinase, and apoptosis. J Immunol 1999;163:6800–9.
32. Manna SK, Gad YP, Mukhopadhyay A, et al.
Suppression of
tumor necrosis factor-activated nuclear
transcription factorkappaB, activator protein-1, c-Jun N-terminal kinase, and
apoptosis by beta-lapachone. Biochem Pharmacol
1999;57:763–
74.
33. Chainy GB, Manna SK, Chaturvedi MM, et al.
Anethole blocks
both early and late cellular responses transduced by
tumor
necrosis factor: effect on NF-kappaB, AP-1, JNK,
MAPKK and
apoptosis. Oncogene 2000;19:2943–50.
34. Manna SK, Sah NK, Newman RA, et al. Oleandrin
suppresses
activation of nuclear transcription factor-kappaB,
activator
protein-1, and c-Jun NH2-terminal kinase. Cancer Res
2000;60:
3838–47.
35. Manna SK, Mukhopadhyay A, Aggarwal BB.
Resveratrol
suppresses TNF-induced activation of nuclear
transcription
factors NF-kappa B, activator protein-1, and
apoptosis: potential
role of reactive oxygen intermediates and lipid
peroxidation. J
Immunol 2000;164:6509–19.
36. Mukhopadhyay A, Bueso-Ramos C, Chatterjee D, et
al. Curcumin
downregulates cell survival mechanisms in human
prostate cancer
cell lines. Oncogene 2001;20:7597–609.
37. Anto RJ, Mukhopadhyay A, Denning K, et al.
Curcumin
(diferuloylmethane) induces apoptosis through
activation of
caspase-8, BID cleavage and cytochrome c release:
its suppression
by ectopic expression of Bcl-2 and Bcl-xl.
Carcinogenesis 2002;23:
143–50.
38. Ashikawa K, Majumdar S, Banerjee S, et al.
Piceatannol inhibits
TNF-induced NF-kappaB activation and
NF-kappaB-mediated
gene expression through suppression of IkappaBalpha
kinase and
p65 phosphorylation. J Immunol 2002;169:6490–7.
39. Banerjee S, Bueso-Ramos C, Aggarwal BB.
Suppression of 7,12-
dimethylbenz(a)anthracene-induced mammary
carcinogenesis in
rats by resveratrol: role of nuclear factor-kappaB,
cyclooxygenase
2, and matrix metalloprotease 9. Cancer Res
2002;62:4945–54.
40. Mukhopadhyay A, Banerjee S, Stafford LJ, et al.
Curcumininduced suppression of cell proliferation correlates with
downregulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein
phosphorylation. Oncogene 2002;21:8852–61.
41. Bharti AC, Donato N, Aggarwal BB. Curcumin
(diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3
phosphorylation in human multiple myeloma cells. J Immunol 2003;
171:3863–71.
42. Bharti AC, Donato N, Singh S, et al. Curcumin
(diferuloylmethane) down-regulates the constitutive activation of nuclear
factor-kappa B and IkappaBalpha kinase in human
multiple
myeloma cells, leading to suppression of
proliferation and
induction of apoptosis. Blood 2003;101:1053–62.
43. Estrov Z, Shishodia S, Faderl S, et al.
Resveratrol blocks
interleukin-1beta-induced activation of the nuclear
transcription
factor NF-kappaB, inhibits proliferation, causes
S-phase arrest,
and induces apoptosis of acute myeloid leukemia
cells. Blood
2003;102:987–95.
44. Manna SK, Bueso-Ramos C, Alvarado F, et al.
Calagualine
inhibits nuclear transcription factors-kappaB
activated by various
inflammatory and tumor promoting agents. Cancer Lett
2003;
190:171–82.
45. Shishodia S, Majumdar S, Banerjee S, et al.
Ursolic acid inhibits
nuclear factor-kappaB activation induced by
carcinogenic agents
through suppression of IkappaBalpha kinase and p65
phosphorylation: correlation with down-regulation of cyclooxygenase 2,
matrix metalloproteinase 9, and cyclin D1. Cancer
Res 2003;63:
4375–83.
46. Shishodia S, Potdar P, Gairola CG, et al.
Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB
activation through inhibition of IkappaBalpha kinase
in human
lung epithelial cells: correlation with suppression
of COX-2,
MMP-9 and cyclin D1. Carcinogenesis 2003;24:1269–79.
47. Takada Y, Aggarwal BB. Betulinic acid suppresses
carcinogeninduced NF-kappa B activation through inhibition of I kappa B
alpha kinase and p65 phosphorylation: abrogation of
cyclooxygenase-2 and matrix metalloprotease-9. J Immunol 2003;171:
3278–86.
48. Aggarwal S, Takada Y, Singh S, et al. Inhibition
of growth and
survival of human head and neck squamous cell
carcinoma cells
by curcumin via modulation of nuclear factor-kappaB
signaling.
Int J Cancer 2004;111:679–92.
49. Bharti AC, Takada Y, Aggarwal BB. Curcumin
(diferuloylmethane) inhibits receptor activator of NF-kappa B ligandinduced
NF-kappa B activation in osteoclast precursors and
suppresses osteoclastogenesis. J Immunol
2004;172:5940–7.
50. Li L, Aggarwal BB, Shishodia S, et al. Nuclear
factor-kappaB and
IkappaB kinase are constitutively active in human
pancreatic cells,
and their down-regulation by curcumin
(diferuloylmethane) is
associated with the suppression of proliferation and
the induction
of apoptosis. Cancer 2004;101:2351–62.
51. Shishodia S, Aggarwal BB. Guggulsterone inhibits
NF-kappaB and
IkappaBalpha kinase activation, suppresses
expression of antiapoptotic gene products, and enhances apoptosis. J Biol Chem
2004;279:47148–58.
52. Takada Y, Aggarwal BB. Flavopiridol inhibits
NF-kappaB
activation induced by various carcinogens and
inflammatory
agents through inhibition of IkappaBalpha kinase and
p65
phosphorylation: abrogation of cyclin D1,
cyclooxygenase-2,
and matrix metalloprotease-9. J Biol Chem
2004;279:4750–9.
53. Aggarwal BB, Shishodia S, Takada Y, et al.
Curcumin suppresses
the paclitaxel-induced nuclear factor-kappaB pathway
in breast
cancer cells and inhibits lung metastasis of human
breast cancer in
nude mice. Clin Cancer Res 2005;11:7490–8.
54. Ichikawa H, Takada Y, Murakami A, et al.
Identification of a
novel blocker of I kappa B alpha kinase that
enhances cellular
apoptosis and inhibits cellular invasion through suppression
of
NF-kappa B-regulated gene products. J Immunol
2005;174:7383–
92.
55. Shishodia S, Amin HM, Lai R, et al. Curcumin
(diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/
S arrest, suppresses proliferation, and induces
apoptosis in mantle
cell lymphoma. Biochem Pharmacol 2005;70:700–13.
56. Siwak DR, Shishodia S, Aggarwal BB, et al.
Curcumin-induced
antiproliferative and proapoptotic effects in
melanoma cells are
associated with suppression of IkappaB kinase and
nuclear factor
kappaB activity and are independent of the
B-Raf/mitogenactivated/extracellular signal-regulated protein kinase pathway
and the Akt pathway. Cancer 2005;104:879–90.
57. Takada Y, Murakami A, Aggarwal BB. Zerumbone
abolishes NFkappaB and IkappaBalpha kinase activation leading to suppression of
antiapoptotic and metastatic gene expression, upregulation of apoptosis, and
downregulation of invasion. Oncogene
2005;24:6957–69.
58. Takada Y, Andreeff M, Aggarwal BB.
Indole-3-carbinol suppresses
NF-kappaB and IkappaBalpha kinase activation,
causing inhibition of expression of NF-kappaB-regulated antiapoptotic and
metastatic gene products and enhancement of
apoptosis in
myeloid and leukemia cells. Blood 2005;106:641–9.
59. Takada Y, Kobayashi Y, Aggarwal BB. Evodiamine
abolishes
constitutive and inducible NF-kappaB activation by
inhibiting
IkappaBalpha kinase activation, thereby suppressing
NF-kappaBregulated antiapoptotic and metastatic gene expression, upregulating
apoptosis, and inhibiting invasion. J Biol Chem 2005;
280:17203–12.
60. Adams LS, Seeram NP, Aggarwal BB, et al.
Pomegranate juice,
total pomegranate ellagitannins, and punicalagin
suppress
inflammatory cell signaling in colon cancer cells. J
Agric Food
Chem 2006;54:980–5.
61. Aggarwal S, Ichikawa H, Takada Y, et al.
Curcumin (diferuloylmethane) down-regulates expression of cell proliferation
and
antiapoptotic and metastatic gene products through
suppression
of IkappaBalpha kinase and Akt activation. Mol
Pharmacol 2006;
69:195–206.
(Contd.)
Comments